MLSC joins Boston Biomedical for the grand opening of its Cambridge headquarters

From left to right: Masayo Tada-san, President and CEO of Dainippon Sumitomo Pharma (DSP) and Chairman of Boston Biomedical, Inc. (BBI), joins Dr. Chiang Li, President and CEO of BBI at the ribbon-cutting ceremony celebrating the opening of BBI’s new office in Cambridge, Mass.
From left to right: Masayo Tada-san, President and CEO of Dainippon Sumitomo Pharma (DSP) and Chairman of Boston Biomedical, Inc. (BBI), joins Dr. Chiang Li, President and CEO of BBI at the ribbon-cutting ceremony celebrating the opening of BBI’s new office in Cambridge, Mass.

Boston Biomedical, Inc., on July 9, 2013, celebrated the relocation of its headquarters to Cambridge, Massachusetts with a grand opening ceremony. Academic, business and government leaders, as well as executives from Dainippon Sumitomo Pharma Co., Ltd. (DSP), the parent company of BBI, joined the celebration.

Share This Post

Announcements
MLSC Brandmark scaled 1